Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05500391 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring

Study acronym: SUR-CAN
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study completion date: Oct 2029 to Jul 2032v8
  2. Re-verified, no change to tracked fieldsv7
  3. Start date changed from estimate of Feb 2024 to Feb 28, 2024v6
  4. Start date: Jan 2024 to Feb 2024v5
  5. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised at 3 of 3 sites
    v4
Show 2 earlier versionsHide 2 earlier versions
  1. Start date: Mar 2023 to Jan 2024
    • Primary completion date: Jun 2026 to Oct 2026
    • Study completion date: Jun 2029 to Oct 2029
    v3
  2. Start date: Jan 2023 to Mar 2023v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Centre Oscar Lambret
100 trials monitored
See 2 trials at risk
Ovarian Cancer
1,336 trials monitored
See 90 trials at risk
Glioma
1,251 trials monitored
See 88 trials at risk
Sarcoma
1,026 trials monitored
See 67 trials at risk
This is a multicenter, interventional, randomized study among adult patients recently diagnosed with a rare tumor (\<12 months). The study will aim to compare compliance with the personalized post-treatment surveillance plan, established for each patient according to national guidelines, when the surveillance is conducted in person by a hospital-based physician (control arm) or remotely by a trained nurse (experimental arm).
Trial Details
NCT Number NCT05500391
Lead Sponsor Centre Oscar Lambret
Collaborators: Canceropôle Nord Ouest, Groupement Interrégional de Recherche Clinique et d'Innovation
Conditions
(from sponsor)		 Stage I Testicular Seminoma, Stage I Testicular Nonseminomatous Germ Cell Tumor, Gastrointestinal Stromal Tumors, Ovarian Germ Cell Tumor, Adenocarcinoma, Clear Cell, Borderline Ovarian Tumor, Sex Cord-Stromal Tumor, Mucinous Adenocarcinoma of Ovary +6 more
Related terms Adenocarcinoma, Clear Cell, Carcinoma, Small Cell, Carcinosarcoma, Gastrointestinal Stromal Tumors, Glioma, Neuroendocrine Tumors, Seminoma, Sex Cord-Gonadal Stromal Tumors
Enrollment 88 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov